Literature DB >> 19665955

Why are Cochrane hepato-biliary reviews undervalued by physicians as an aid for clinical decision-making?

L Pagliaro1, P Bruzzi, M Bobbio.   

Abstract

BACKGROUND: Cochrane systematic reviews are of higher quality than reviews published in scientific journals, yet are used less than other sources for clinical decision-making. AIM: To assess whether the characteristics of the Cochrane systematic reviews can account for their scant use by physicians.
MATERIALS AND METHODS: We analysed the 87 Cochrane hepato-biliary reviews dealing with therapeutic topics posted in the Cochrane Database of Systematic Reviews through December 2008, which we classified according to four characteristics: empty reviews; outdated reviews; content of reviews; implications for practice.
RESULTS: Six empty reviews found no eligible randomised trials and six found one trial, precluding a systematic review; some empty reviews investigated irrelevant topics. Twenty-one reviews investigated outdated interventions, and thirteen of them were posted ten or more years after the publication of the most recent trial included. Most reviews were too lengthy (median: 40 pages) and their consultation was time-consuming with respect to clinical content. They generally compared two treatments, disregarding other options, and usually did not report any non-randomised (although convincing) evidence of potential use in clinical decision-making.
CONCLUSIONS: If generalized to the entire Cochrane Database of Systematic Reviews, these characteristics may largely explain why physicians undervalue the Cochrane reviews as a source of evidence for clinical decision-making. Copyright (c) 2009 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Mesh:

Year:  2009        PMID: 19665955     DOI: 10.1016/j.dld.2009.07.003

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  3 in total

1.  Characteristics of registered and published systematic reviews focusing on the prevention of COVID-19: a meta-research study.

Authors:  Julia Nothacker; Julia Stadelmaier; Waldemar Siemens; Joerg J Meerpohl; Christine Schmucker
Journal:  BMJ Open       Date:  2022-05-09       Impact factor: 3.006

2.  Bibliometrics of systematic reviews: analysis of citation rates and journal impact factors.

Authors:  Pamela Royle; Ngianga-Bakwin Kandala; Katharine Barnard; Norman Waugh
Journal:  Syst Rev       Date:  2013-09-12

3.  Empty reviews: a description and consideration of Cochrane systematic reviews with no included studies.

Authors:  Joanne Yaffe; Paul Montgomery; Sally Hopewell; Lindsay Dianne Shepard
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.